A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling

Fms-like tyrosine kinase-3 is a commonly mutated gene in acute myeloid leukemia, with about one-third of patients carrying an internal-tandem duplication of the juxtamembrane domain in the receptor (FLT3-ITD). FLT3-ITD exhibits altered signaling quality, including aberrant activation of STAT5. To id...

Full description

Bibliographic Details
Main Authors: Caldarelli, A, Müller, J P, Paskowski-Rogacz, M, Herrmann, K, Bauer, R, Koch, S, Heninger, A K, Krastev, D, Ding, L, Kasper, S, Fischer, T, Brodhun, M, Böhmer, F-D, Buchholz, F
Format: Online
Language:English
Published: Nature Publishing Group 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3865536/
id pubmed-3865536
recordtype oai_dc
spelling pubmed-38655362013-12-17 A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling Caldarelli, A Müller, J P Paskowski-Rogacz, M Herrmann, K Bauer, R Koch, S Heninger, A K Krastev, D Ding, L Kasper, S Fischer, T Brodhun, M Böhmer, F-D Buchholz, F Original Article Fms-like tyrosine kinase-3 is a commonly mutated gene in acute myeloid leukemia, with about one-third of patients carrying an internal-tandem duplication of the juxtamembrane domain in the receptor (FLT3-ITD). FLT3-ITD exhibits altered signaling quality, including aberrant activation of STAT5. To identify genes affecting FLT3-ITD-mediated STAT5 signaling, we performed an esiRNA-based RNAi screen utilizing a STAT5-driven reporter assay. Knockdowns that caused reduced FLT3-ITD-mediated STAT5 signaling were enriched for genes encoding proteins involved in protein secretion and intracellular protein transport, indicating that modulation of protein transport processes could potentially be used to reduce constitutive STAT5 signaling in FLT3-ITD-positive cells. The relevance of KDELR1, a component involved in the Golgi-ER retrograde transport, was further analyzed. In FLT3-ITD-expressing leukemic MV4-11 cells, downregulation of KDELR1 resulted in reduced STAT5 activation, proliferation and colony-forming capacity. Stable shRNA-mediated depletion of KDELR1 in FLT3-ITD-expressing 32D cells likewise resulted in reduced STAT5 signaling and cell proliferation. Importantly, these cells also showed a reduced capacity to generate a leukemia-like disease in syngeneic C3H/HeJ mice. Together our data suggest intracellular protein transport as a potential target for FLT3-ITD driven leukemias, with KDELR1 emerging as a positive modulator of oncogenic FLT3-ITD activity. Nature Publishing Group 2013-12 2013-04-12 /pmc/articles/PMC3865536/ /pubmed/23508117 http://dx.doi.org/10.1038/leu.2013.83 Text en Copyright © 2013 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Caldarelli, A
Müller, J P
Paskowski-Rogacz, M
Herrmann, K
Bauer, R
Koch, S
Heninger, A K
Krastev, D
Ding, L
Kasper, S
Fischer, T
Brodhun, M
Böhmer, F-D
Buchholz, F
spellingShingle Caldarelli, A
Müller, J P
Paskowski-Rogacz, M
Herrmann, K
Bauer, R
Koch, S
Heninger, A K
Krastev, D
Ding, L
Kasper, S
Fischer, T
Brodhun, M
Böhmer, F-D
Buchholz, F
A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling
author_facet Caldarelli, A
Müller, J P
Paskowski-Rogacz, M
Herrmann, K
Bauer, R
Koch, S
Heninger, A K
Krastev, D
Ding, L
Kasper, S
Fischer, T
Brodhun, M
Böhmer, F-D
Buchholz, F
author_sort Caldarelli, A
title A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling
title_short A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling
title_full A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling
title_fullStr A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling
title_full_unstemmed A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling
title_sort genome-wide rnai screen identifies proteins modulating aberrant flt3-itd signaling
description Fms-like tyrosine kinase-3 is a commonly mutated gene in acute myeloid leukemia, with about one-third of patients carrying an internal-tandem duplication of the juxtamembrane domain in the receptor (FLT3-ITD). FLT3-ITD exhibits altered signaling quality, including aberrant activation of STAT5. To identify genes affecting FLT3-ITD-mediated STAT5 signaling, we performed an esiRNA-based RNAi screen utilizing a STAT5-driven reporter assay. Knockdowns that caused reduced FLT3-ITD-mediated STAT5 signaling were enriched for genes encoding proteins involved in protein secretion and intracellular protein transport, indicating that modulation of protein transport processes could potentially be used to reduce constitutive STAT5 signaling in FLT3-ITD-positive cells. The relevance of KDELR1, a component involved in the Golgi-ER retrograde transport, was further analyzed. In FLT3-ITD-expressing leukemic MV4-11 cells, downregulation of KDELR1 resulted in reduced STAT5 activation, proliferation and colony-forming capacity. Stable shRNA-mediated depletion of KDELR1 in FLT3-ITD-expressing 32D cells likewise resulted in reduced STAT5 signaling and cell proliferation. Importantly, these cells also showed a reduced capacity to generate a leukemia-like disease in syngeneic C3H/HeJ mice. Together our data suggest intracellular protein transport as a potential target for FLT3-ITD driven leukemias, with KDELR1 emerging as a positive modulator of oncogenic FLT3-ITD activity.
publisher Nature Publishing Group
publishDate 2013
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3865536/
_version_ 1612039042215444480